Authors:
LIVERIS D
WORMSER GP
NOWAKOWSKI J
NADELMAN R
BITTKER S
COOPER D
VARDE S
MOY FH
FORSETER G
PAVIA CS
SCHWARTZ I
Citation: D. Liveris et al., MOLECULAR TYPING OF BORRELIA-BURGDORFERI FROM LYME-DISEASE PATIENTS BY PCR-RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS, Journal of clinical microbiology, 34(5), 1996, pp. 1306-1309
Authors:
NADELMAN RB
NOWAKOWSKI J
FORSETER G
GOLDBERG NS
BITTKER S
COOPER D
AGUEROROSENFELD M
WORMSER GP
Citation: Rb. Nadelman et al., THE CLINICAL SPECTRUM OF EARLY LYME BORRELIOSIS IN PATIENTS WITH CULTURE-CONFIRMED ERYTHEMA MIGRANS, The American journal of medicine, 100(5), 1996, pp. 502-508
Authors:
NOWAKOWSKI J
NADELMAN RB
FORSETER G
MCKENNA D
WORMSER GP
Citation: J. Nowakowski et al., DOXYCYCLINE VERSUS TETRACYCLINE THERAPY FOR LYME-DISEASE ASSOCIATED WITH ERYTHEMA MIGRANS, Journal of the American Academy of Dermatology, 32(2), 1995, pp. 223-227
Citation: G. Forseter et al., IS ZIDOVUDINE A PROPHYLACTIC TREATMENT FOR HEALTH-CARE WORKERS - IN REPLY, Archives of internal medicine, 155(16), 1995, pp. 1816-1817
Authors:
HOROWITZ HW
PAVIA CS
BITTKER S
FORSETER G
COOPER D
NADELMAN RB
BYRNE D
JOHNSON RC
WORMSER GP
Citation: Hw. Horowitz et al., SUSTAINED CELLULAR IMMUNE-RESPONSES TO BORRELIA-BURGDORFERI - LACK OFCORRELATION WITH CLINICAL PRESENTATION AND SEROLOGY, Clinical and diagnostic laboratory immunology, 1(4), 1994, pp. 373-378
Citation: G. Forseter et al., TOLERABILITY, SAFETY, AND ACCEPTABILITY OF ZIDOVUDINE PROPHYLAXIS IN HEALTH-CARE WORKERS, Archives of internal medicine, 154(23), 1994, pp. 2745-2749
Authors:
NADELMAN RB
NOWAKOWSKI J
FORSETER G
BITTKER S
COOPER D
GOLDBERG N
MCKENNA D
WORMSER GP
Citation: Rb. Nadelman et al., FAILURE TO ISOLATE BORRELIA-BURGDORFERI AFTER ANTIMICROBIAL THERAPY IN CULTURE-DOCUMENTED LYME BORRELIOSIS ASSOCIATED WITH ERYTHEMA MIGRANS- REPORT OF A PROSPECTIVE-STUDY, The American journal of medicine, 94(6), 1993, pp. 583-588